NCT00765076View on ClinicalTrials.gov

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

October 16, 2008

Primary Completion Date

December 4, 2009

Study Completion Date

December 4, 2009

Conditions
Influenza
Interventions
BIOLOGICAL

GSK Biologicals' influenza vaccine GSK2186877A

One intramuscular injection at Day 0

BIOLOGICAL

GSK Biologicals' Fluarix

One intramuscular injection at Day 0

Trial Locations (4)

28040

GSK Investigational Site, Marid

28046

GSK Investigational Site, Madrid

77030

GSK Investigational Site, Houston

08035

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00765076 - Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older | Biotech Hunter | Biotech Hunter